BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Treatment
96 results:

  • 1. Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study.
    Simmons DJ; Valerio SJ; Thomas DS; Healey MJ; Jiang Z; Levingston Mac Leod JM; Lin Y; Sah J
    Adv Ther; 2024 Apr; 41(4):1711-1727. PubMed ID: 38443649
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors.
    Arnold LM; Hoshina Y; Lee H; Colman H; Mendez J
    J Neurooncol; 2024 Mar; 167(1):211-217. PubMed ID: 38363493
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Outcome of Epilepsy Surgery in MRI-Negative Patients Without Histopathologic Abnormalities in the Resected Tissue.
    Sanders MW; Van der Wolf I; Jansen FE; Aronica E; Helmstaedter C; Racz A; Surges R; Grote A; Becker AJ; Rheims S; Catenoix H; Duncan JS; De Tisi J; Jacques TS; Cross JH; Kalviainen R; Rauramaa T; Chassoux F; Devaux BC; Di Gennaro G; Esposito V; Bodi I; Honavar M; Bien CG; Cloppenborg T; Coras R; Hamer HM; Marusic P; Kalina A; Pieper T; Kudernatsch M; Hartlieb TS; Von Oertzen TJ; Aichholzer M; Dorfmuller G; Chipaux M; Noachtar S; Kaufmann E; Schulze-Bonhage A; Scheiwe CF; Özkara C; Grunwald T; Koenig K; Guerrini R; Barba C; Buccoliero AM; Giordano F; Rosenow F; Menzler K; Garbelli R; Deleo F; Krsek P; Straka B; Arzimanoglou AA; Toulouse J; Van Paesschen W; Theys T; Pimentel J; Loução De Amorim IM; Specchio N; De Palma L; Feucht M; Scholl T; Roessler K; Toledano Delgado R; Gil-Nagel A; Raicevic S; Ristic AJ; Schijns O; Beckervordersandforth J; San Antonio-Arce V; Rumia J; Blumcke I; Braun KP;
    Neurology; 2024 Feb; 102(4):e208007. PubMed ID: 38290094
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults.
    Tang T; Wang Y; Dai Y; Liu Q; Fan X; Cheng Y; Tang J; Xiao X; Shan Y; Wei P; Zhao G
    Pathol Res Pract; 2024 Feb; 254():155165. PubMed ID: 38286053
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma.
    Lu Y; Liao L; Du K; Mo J; Zou X; Liang J; Chen J; Tang W; Su L; Wu J; Zhang J; Tan Y
    BMC Cancer; 2024 Jan; 24(1):133. PubMed ID: 38273249
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of cancer history on long-term outcome after elective neuro-endovascular treatment in patients aged 80 years or older: A retrospective multicenter observational study.
    Fujita K; Sato Y; Hanazawa R; Sagawa H; Ishikawa M; Fujii S; Aoyama J; Hirai S; Yoshimura M; Yoshino Y; Kawano Y; Shigeta K; Taira N; Karakama J; Ishiwada T; Yamashina M; Hirakawa A; Sumita K
    Geriatr Gerontol Int; 2024 Feb; 24(2):211-217. PubMed ID: 38126478
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patients.
    Osorio RC; Haddad AF; Hart DM; Goldrich N; Badani A; Kabir AS; Juncker R; Oh JY; Carrete L; Peeran Z; Chalif EJ; Zheng AC; Braunstein S; Theodosopoulos PV; El-Sayed IH; Gurrola J; Kunwar S; Blevins LS; Aghi MK
    J Neurosurg; 2024 Mar; 140(3):712-723. PubMed ID: 37877974
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder.
    Meshkat S; Teopiz KM; Di Vincenzo JD; Bailey JB; Rosenblat JD; Ho RC; Rhee TG; Ceban F; Kwan ATH; Cao B; McIntyre RS
    J Affect Disord; 2023 Nov; 340():893-898. PubMed ID: 37557991
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Efficacy of stereotactic radiation therapy for the treatment of confirmed or presumed canine glioma.
    Trageser E; Martin T; Burdekin B; Hart C; Leary D; LaRue S; Boss MK
    Vet Comp Oncol; 2023 Dec; 21(4):578-586. PubMed ID: 37423611
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Apigetrin-enriched Pulmeria alba extract prevents assault of STZ on pancreatic β-cells and neuronal oxidative stress with concomitant attenuation of tissue damage and suppression of inflammation in the brain of diabetic rats.
    Abdulrasheed-Adeleke T; Lawal B; Agwupuye EI; Kuo Y; Eni AM; Ekoh OF; Lukman HY; Onikanni AS; Olawale F; Saidu S; Ibrahim YO; Al Ghamdi MAS; Aggad SS; Alsayegh AA; Aljarba NH; Batiha GE; Wu ATH; Huang HS
    Biomed Pharmacother; 2023 Jun; 162():114582. PubMed ID: 36989727
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cardiovascular morbidity following conventional therapy versus allogeneic hematopoietic stem cell transplantation after childhood, adolescent, and young adult leukemia in Finland.
    Kero AE; Taskinen M; Volin L; Löyttyniemi E; Itälä-Remes M; Lähteenmäki PM
    Int J Cancer; 2023 Jun; 152(11):2292-2302. PubMed ID: 36760204
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy, Safety, and Health-Related Quality of Life With Camrelizumab Plus Pemetrexed and Carboplatin as First-Line treatment for Advanced Nonsquamous NSCLC With brain Metastases (CAP-brain): A Multicenter, Open-Label, Single-Arm, Phase 2 Study.
    Hou X; Zhou C; Wu G; Lin W; Xie Z; Zhang H; Yi J; Peng Z; Yin L; Ma C; Chen L
    J Thorac Oncol; 2023 Jun; 18(6):769-779. PubMed ID: 36738928
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effects of vonoprazan and proton pump inhibitors on the efficacy of bevacizumab: a multicentre retrospective study.
    Yagi K; Maruo A; Ishida S; Aizawa F; Ushio S; Sakaguchi S; Kajizono M; Niimura T; Goda M; Hamano H; Izawa-Ishizawa Y; Zamami Y; Ishizawa K
    Clin Exp Med; 2023 Oct; 23(6):2799-2804. PubMed ID: 36738305
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Serplulimab plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: A cost-effectiveness analysis.
    Zhu Y; Liu K; Qin Q; Zhu H
    Front Immunol; 2022; 13():1044678. PubMed ID: 36685541
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Quantitative analysis of MGMT promoter methylation status changes by pyrosequencing in recurrent glioblastoma.
    Jiménez VG; Doval MB; Bellvert CG; Goliney VG; Asencio OS; Martín AG; Domínguez JI
    Neuropathology; 2023 Aug; 43(4):306-312. PubMed ID: 36504469
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Ophthalmological Findings in Youths With a Newly Diagnosed brain Tumor.
    Nuijts MA; Stegeman I; van Seeters T; Borst MD; Bennebroek CAM; Buis DR; Naus NC; Porro GL; van Egmond-Ebbeling MB; Voskuil-Kerkhof ESM; Pott JR; Franke NE; de Vos-Kerkhof E; Hoving EW; Schouten-van Meeteren AYN; Imhof SM
    JAMA Ophthalmol; 2022 Oct; 140(10):982-993. PubMed ID: 36107418
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Five-year symptomatic hemorrhage risk of untreated brainstem cavernous malformations in a prospective cohort.
    Kong L; Ma XJ; Xu XY; Liu PP; Wu ZY; Zhang LW; Zhang JT; Wu Z; Wang L; Li D
    Neurosurg Rev; 2022 Aug; 45(4):2961-2973. PubMed ID: 35633420
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Wang J; Zhou C; Yao W; Wang Q; Min X; Chen G; Xu X; Li X; Xu F; Fang Y; Yang R; Yu G; Gong Y; Zhao J; Fan Y; Liu Q; Cao L; Yao Y; Liu Y; Li X; Wu J; He Z; Lu K; Jiang L; Hu C; Zhao W; Zhang B; Shi W; Zhang X; Cheng Y;
    Lancet Oncol; 2022 Jun; 23(6):739-747. PubMed ID: 35576956
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A survey by the European Society of Breast Imaging on the implementation of breast diffusion-weighted imaging in clinical practice.
    Lo Gullo R; Sevilimedu V; Baltzer P; Le Bihan D; Camps-Herrero J; Clauser P; Gilbert FJ; Iima M; Mann RM; Partridge SC; Patterson A; Sigmund EE; Thakur S; Thibault FE; Martincich L; Pinker K;
    Eur Radiol; 2022 Oct; 32(10):6588-6597. PubMed ID: 35507050
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Dosimetric feasibility of hippocampal avoidance whole brain radiotherapy with an MRI-guided linear accelerator.
    Graham JA; Redler G; Delozier KB; Yu HM; Oliver DE; Rosenberg SA
    J Appl Clin Med Phys; 2022 Jun; 23(6):e13587. PubMed ID: 35344266
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.